Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy.
about
Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) with Low-Dose Cisplatin and Doxorubicin in Gastric Peritoneal Metastasis.Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosisPressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report.Dynamic changes of tumor gene expression during repeated pressurized intraperitoneal aerosol chemotherapy (PIPAC) in women with peritoneal cancer.Technical description of the microinjection pump (MIP®) and granulometric characterization of the aerosol applied for pressurized intraperitoneal aerosol chemotherapy (PIPAC).Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report.Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosisIn Vivo Feasibility of Electrostatic Precipitation as an Adjunct to Pressurized Intraperitoneal Aerosol Chemotherapy (ePIPAC).Cytotoxic effect of different treatment parameters in pressurized intraperitoneal aerosol chemotherapy (PIPAC) on the in vitro proliferation of human colonic cancer cellsImpact of Pressurized Intraperitoneal Aerosol Chemotherapy on Quality of Life and Symptoms in Patients with Peritoneal Carcinomatosis: A Retrospective Cohort Study.Feasibility and Safety of Pressurized Intraperitoneal Aerosol Chemotherapy for Peritoneal Carcinomatosis: A Retrospective Cohort Study.Pressurized intraperitoneal chemotherapy (PIPAC) in women with gynecologic malignancies: a review.Tumour tissue transport after intraperitoneal anticancer drug delivery.Scintigraphic peritoneography reveals a non-uniform (99m)Tc-Pertechnetat aerosol distribution pattern for Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a swine model.Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC).Treatment of peritoneal metastases from small bowel adenocarcinoma.Acetic acid induces cell death: an in vitro study using normal rat gastric mucosal cell line and rat and human gastric cancer and mesothelioma cell lines.Exploring the Spatial Drug Distribution Pattern of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC).Effect of Irradiation on Tissue Penetration Depth of Doxorubicin after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in a Novel Ex-Vivo Model.Pressurized Intra Peritoneal Aerosol Chemotherapy in patients suffering from peritoneal carcinomatosis of pancreatic adenocarcinoma.Inflammatory Response and Toxicity After Pressurized IntraPeritoneal Aerosol Chemotherapy.Nanoparticle as a novel tool in hyperthermic intraperitoneal and pressurized intraperitoneal aerosol chemotheprapy to treat patients with peritoneal carcinomatosis.Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Procedure for Non-resectable Peritoneal Carcinomatosis (with Video).Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept.Distribution pattern and penetration depth of doxorubicin after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a postmortem swine model.Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study.Pseudomyxoma Peritonei: A Case Report Diagnosed in a 47-Year-Old Woman with Chronic Pelvic Abdominal Pain and Appendicular Origin: Review of the Literature and Management.Feasibility of hyperthermic pressurized intraperitoneal aerosol chemotherapy in a porcine model.Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis.Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) for the treatment of malignant mesothelioma.Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma.Treatment of patients with peritoneal metastases from gastric cancer.Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis
P2860
Q27313250-5152E372-5E4F-4749-8C55-DC2DC72A364EQ29994639-AA0A7CE4-A54E-47C4-807F-C7CA57B7519DQ35614095-C74693E2-F762-400D-95AF-1277FCC60FA4Q36108028-D4344254-BFBA-40FC-8290-B94832463949Q36133743-A3A9D740-4F05-4AF6-9C6B-ADBA8AE77D16Q36243127-E404A573-0119-4FD7-98F8-9A407FF39530Q36851100-B14DF34A-B1F9-4DB6-B78F-63D19B1411D9Q37492164-66CEA511-09FC-4815-82FA-FE3372384F11Q37635345-596DD94A-B1AE-45AD-9186-CF7683E739B2Q37683464-04A2C414-F9D4-4FD6-8FD6-7A1AA86B9A5FQ37694182-425CAFD0-1E68-4B47-AB4D-C794716A8229Q38253577-C4CC4940-31DC-4206-ADDB-A6C5694C9A0AQ38679465-FE89F1A8-C676-486F-9F55-9A89128EB03FQ38712794-6CCA94D1-C2B0-4684-A158-6C50A301E150Q38779523-FF18603C-7639-4EBD-9F04-1FA55767E71CQ38787018-909E3E2F-7747-4DE6-AE91-259D70454559Q38927387-9135D6CC-4727-449E-BB05-159F99AF6B75Q40339044-7E3D0E1F-AF82-4555-8A24-3B30B43C645DQ42698382-3F821B17-A0C4-49F2-A4D9-1A423C2E3588Q44424534-28F1C16E-E0DB-4C5C-8D1D-D3BC285A029BQ47109168-4765D285-CEB0-45C1-8F4A-6DF54A45F826Q47165034-7DF48151-46E8-45E9-B674-AD26AB84C20DQ47253274-BCD7265D-EBB7-452D-88D9-0BD08DAE442FQ48200710-12ABE1C7-3E45-4F84-8D56-CBF6FC409E95Q48533666-F0173690-8E01-4CEF-928A-8A8E170EADA4Q48830395-B9D806E2-BFA0-4656-8593-742EE6E99523Q49177631-DDD4E65D-311C-4E22-B441-EC1A922D1868Q50236269-28672FC5-E24F-40DC-82B7-FADD7430CE68Q51709594-768A03F7-69B7-496F-AB85-9CC57F0DEC4BQ52579981-65708D78-25C4-4D53-A237-5FF43F027AA8Q52866005-F09C2CD4-C369-401E-BE91-3602A8B52833Q55318427-05A29949-0548-4F97-8971-C4E5E5412717Q55376619-1D613B1E-6EB4-42AF-8F08-6EBE069F402CQ58566712-ED1B9508-D295-4A6C-AE4E-F7E9A801F877
P2860
Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intraperitoneal chemotherapy o ...... : first evidence for efficacy.
@en
Intraperitoneal chemotherapy o ...... : first evidence for efficacy.
@nl
type
label
Intraperitoneal chemotherapy o ...... : first evidence for efficacy.
@en
Intraperitoneal chemotherapy o ...... : first evidence for efficacy.
@nl
prefLabel
Intraperitoneal chemotherapy o ...... : first evidence for efficacy.
@en
Intraperitoneal chemotherapy o ...... : first evidence for efficacy.
@nl
P2093
P2860
P1476
Intraperitoneal chemotherapy o ...... n: first evidence for efficacy
@en
P2093
Dirk Strumberg
Jürgen Zieren
Marc André Reymond
Matthias Schwab
Reinhold Kerb
Thomas Mürdter
Urs Giger-Pabst
P2860
P2888
P304
P356
10.1245/S10434-013-3213-1
P577
2013-09-05T00:00:00Z
P5875
P6179
1036384872